수핵 절제술 후 요추에 PerQdisc 인공 임플란트를 수술적으로 삽입 3 (LOPAIN3)
인체적용시험에서 최초 요추 수핵절제술 후 PerQdisc 인공 임플란트 수술적 삽입 "LOPAIN3"
This study is a First in Human, prospective, multi-center clinical study intended to collect safety and performance information for the Spinal Stabilization Technologies PerQdisc® Nucleus Replacement System and procedure concurrently following a successful discectomy using a minimally invasive posterolateral (MIPL) approach. Patients that are at least 21 years or older, presenting with symptomatic radiculopathy from a focal lumbar disc herniation that requires surgical decompression will be included in this study.
연구 개요
상태
상세 설명
The PerQdisc® Nucleus Replacement System is comprised of an in situ formed silicone-based prosthesis with its delivery system, implant fill device, dispenser gun, a disc access system and two different imaging balloons. For this trial, the PerQdisc® will be implanted using minimally invasive posterolateral (MIPL) approach. The implanted device provides an effective means of replacing dysfunctional nucleus pulposus while supporting the native annulus fibrosis to bridge annular defects.
Patients that suffer clinically significant lumbar disc herniations currently undergo discectomy procedures to relieve nerve root compression. The standard discectomy procedure does not correct the annular defect associated with the herniation and is associated with a risk for re-herniation. In addition, the progressive loss of disc height and overall lack of disc turgor and weight bearing capacity is thought to be associated with downstream degenerative changes that may lead to chronic low back pain and premature spondylosis.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Patient is skeletally mature and at least 21 years of age.
- Patient has a lumbar disc herniation, between L1-S1, with compressive radiculopathy of the traversing nerve root requiring partial discectomy or sequestrectomy. Only one lumbar disc may be treated with the PerQdisc device.
- Patient must have an overall disc herniation (extrusion or protrusion) such that half or less of the width of the dorsal annulus of the spinal canal, is affected by the herniation. The width of the canal is defined by the lateral recesses and the central canal (i.e. pedicle to pedicle).
- Patient must have a minimum of 6 mm of disc height as measured in the center of the affected disc.
- Patient is willing and able to give informed consent.
- All surgeries must be approved by at least 2 members of the Medical Advisory Board (MAB) - potential anatomical limitations of safely accessing Kambin's, extent of annular disruption, as well as overall patient criteria will be evaluated
Exclusion Criteria:
- Patient has had prior lumbar spine surgery at the index level (nucleoplasy is acceptable).
- Patient has had spinal fusion in the lumbar spine. Cervical or thoracic fusion is allowed as long as there are no neurologic deficits in the lower extremities.
- Patient has spondyloarthropathy or other spondylolisthesis greater than 4 mm or spondylolysis at the index level (on standing X-ray).
- Patient has underlying moderate or severe spinal stenosis (congenital, degenerative, or due to epidural lipomatosis) at any level. If the index level shows stenosis due to the disc herniation, it is acceptable if the index level is going to be treated concurrently with the PerQdsic procedure.
- Patient has compressive radiculopathy of the exiting nerve root at the index level.
- Patient has significant facet disease. Significant is defined as clinically confirmed by diagnostic block or radiologically grade 2 or higher (mild joint narrowing and irregularity are acceptable, but not sclerosis or osteophyte formation).
- Patient has any known active malignancy.
- Patient has previously undergone or currently on immunosuppressive therapy. Steroids used to treat inflammation are allowed.
- Patient has active local or systemic infection.
- Patient has been diagnosed with hepatitis, rheumatoid arthritis, lupus erythematosus, or other autoimmune disease including AIDS, AIDS related complex (ARC) and HIV.
- Patient has diabetes mellitus (Type 1 or 2) requiring daily insulin management.
- Patient has osteopenia of the spine (T-score of -1.0 or lower). All patients 50 years of age or older, and any post menopausal women with a history of fractures should have a dual x-ray absorptiometry (DEXA) scan to confirm exclusion.
- Patient has morbid obesity defined as a body mass index (BMI) more than 35 (>35).
- Patient has a known allergy to silicone or barium sulfate.
- Patient has a broad disc herniation that is wider than ½ of the dorsal annulus forming the wall of the spinal canal
- Patient requires decompression involving disruption of the midline bony-ligamentous elements (i.e. laminectomy).
- Patient has a significant Schmorl's node at the level to be treated, or any Schmorl's nodes affecting 3 or more lumbar levels. Significant is defined as a large, rectangular or irregular shaped node that has an associated active inflammatory process (Modic I changes).
- Patient has more than 20 degrees of mobility on flexion/extension radiographs at the index level
- Patient has more than 10 degrees of lumbar scoliosis.
- Patient belongs to a vulnerable population or has a condition such that his/her ability to provide informed consent, comply with follow-up requirements, or provide self-assessments is compromised (e.g. developmentally disabled, prisoner, chronic alcohol/ substance abuser)
- Patient is pregnant or plans to become pregnant during the course of the study. Pregnancy ruled out by serum HCG. If patient becomes pregnant during the course of the study and wishes to continue study participation, a new Pregnancy Informed Consent must be completed.
Intraoperative Exclusion:
- Poor radiological visualization of Kambin's triangle
- Patient has annular defect following surgical treatment of the disc herniation/protrusion that is greater than 6 mm
- Sustained irritation of the exiting nerve root during any aspect of the annular dilation technique (leg movement or if performing with electrical monitoring) in spite of repositioning instruments.
- Protrusion of the 50A Imaging Balloon up to or beyond the outer margin of the vertebra during the imaging steps.
- Patient has a violated endplate as determined by imaging balloons during fluoroscopy.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Lumbar Disc Nucleus Replacement following discectomy
All patients meeting all inclusion criteria and no exclusion criteria will be considered for nucleus replacement surgery following a review by the Medical Advisory Board. |
Lumbar spine disc nucleus replacement system. All patients meeting all inclusion criteria and no exclusion criteria will be considered for nucleus replacement surgery following a review by the Medical Advisory Board. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Safety: Number of Patients with Serious Adverse Events related to the PerQdisc
기간: 12 months
|
Freedom from device- and procedure-related serious adverse events definitely related to the PerQdisc Device or the PerQdisc Surgical Procedure |
12 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Performance: ODI
기간: 3 months
|
Change in Oswestry Disability Index (ODI) comparing baseline to follow up visits using a patient reported outcome tool |
3 months
|
|
Performance: ODI
기간: 6 months
|
Change in Oswestry Disability Index (ODI) comparing baseline to follow up visits using a patient reported outcome tool |
6 months
|
|
Performance: ODI
기간: 12 months
|
Change in Oswestry Disability Index (ODI) comparing baseline to follow up visits using a patient reported outcome tool |
12 months
|
|
Performance: ODI
기간: 24 months
|
Change in Oswestry Disability Index (ODI) comparing baseline to follow up visits using a patient reported outcome tool |
24 months
|
|
Performance: VAS Back
기간: 3 months
|
Change in back pain values as measured by the 100 millimeter Visual Analog Scale (VAS) |
3 months
|
|
Performance: VAS Back
기간: 6 months
|
Change in back pain values as measured by the 100 millimeter Visual Analog Scale (VAS) |
6 months
|
|
Performance: VAS Back
기간: 12 months
|
Change in back pain values as measured by the 100 millimeter Visual Analog Scale (VAS) |
12 months
|
|
Performance: VAS Back
기간: 24 months
|
Change in back pain values as measured by the 100 millimeter Visual Analog Scale (VAS) |
24 months
|
|
Performance: VAS Leg
기간: 3 months
|
Change in leg pain values as measured by the 100 millimeter Visual Analog Scale (VAS) |
3 months
|
|
Performance: VAS Leg
기간: 6 months
|
Change in leg pain values as measured by the 100 millimeter Visual Analog Scale (VAS) |
6 months
|
|
Performance: VAS Leg
기간: 12 months
|
Change in leg pain values as measured by the 100 millimeter Visual Analog Scale (VAS) |
12 months
|
|
Performance: VAS Leg
기간: 24 months
|
Change in leg pain values as measured by the 100 millimeter Visual Analog Scale (VAS) |
24 months
|
|
Performance: Analgesic Score
기간: 3 months
|
Change in level of pain medication used comparing baseline to follow up visits based on a medication scale from 0 (no meds) to 4 (high dose opioids) |
3 months
|
|
Performance: Analgesic Score
기간: 6 months
|
Change in level of pain medication used comparing baseline to follow up visits based on a medication scale from 0 (no meds) to 4 (high dose opioids) |
6 months
|
|
Performance: Analgesic Score
기간: 12 months
|
Change in level of pain medication used comparing baseline to follow up visits based on a medication scale from 0 (no meds) to 4 (high dose opioids) |
12 months
|
|
Performance: Analgesic Score
기간: 24 months
|
Change in level of pain medication used comparing baseline to follow up visits based on a medication scale from 0 (no meds) to 4 (high dose opioids) |
24 months
|
|
Safety: Number of Patients with Reherniation/recurrent disc herniation
기간: 3 months
|
Freedom from reherniation/recurrent disc herniation |
3 months
|
|
Safety: Number of Patients with Reherniation/recurrent disc herniation
기간: 6 months
|
Freedom from reherniation/recurrent disc herniation |
6 months
|
|
Safety: Number of Patients with Reherniation/recurrent disc herniation
기간: 12 months
|
Freedom from reherniation/recurrent disc herniation |
12 months
|
|
Safety: Number of Patients with Reherniation/recurrent disc herniation
기간: 24 months
|
Freedom from reherniation/recurrent disc herniation |
24 months
|
|
Safety: Number of Patient that Received Supplemental fixation
기간: 3 months
|
Freedom from supplemental fixation at the index level(s) including basivertebral nerve ablation, radiofrequency ablation or spinal cord stimulator |
3 months
|
|
Safety: Number of Patient that Received Supplemental fixation
기간: 6 months
|
Freedom from supplemental fixation at the index level(s) including basivertebral nerve ablation, radiofrequency ablation or spinal cord stimulator |
6 months
|
|
Safety: Number of Patient that Received Supplemental fixation
기간: 12 months
|
Freedom from supplemental fixation at the index level(s) including basivertebral nerve ablation, radiofrequency ablation or spinal cord stimulator |
12 months
|
|
Safety: Number of Patient that Received Supplemental fixation
기간: 24 months
|
Freedom from supplemental fixation at the index level(s) including basivertebral nerve ablation, radiofrequency ablation or spinal cord stimulator |
24 months
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Exploratory Endpoint: Disch Height
기간: 3 months
|
Disc height in millimeters at each clinical visit as measured on plain film X-ray |
3 months
|
|
Exploratory Endpoint: Disch Height
기간: 6 months
|
Disc height in millimeters at each clinical visit as measured on plain film X-ray |
6 months
|
|
Exploratory Endpoint: Disch Height
기간: 12 months
|
Disc height in millimeters at each clinical visit as measured on plain film X-ray |
12 months
|
|
Exploratory Endpoint: Disch Height
기간: 24 months
|
Disc height in millimeters at each clinical visit as measured on plain film X-ray |
24 months
|
|
Exploratory Endpoint: RoM
기간: 3 months
|
Preservation of range of movement (expressed in degrees) at the index and adjacent levels at baseline compared to follow-up using flexion/extension radiographs |
3 months
|
|
Exploratory Endpoint: RoM
기간: 6 months
|
Preservation of range of movement (expressed in degrees) at the index and adjacent levels at baseline compared to follow-up using flexion/extension radiographs |
6 months
|
|
Exploratory Endpoint: RoM
기간: 12 months
|
Preservation of range of movement (expressed in degrees) at the index and adjacent levels at baseline compared to follow-up using flexion/extension radiographs |
12 months
|
|
Exploratory Endpoint: RoM
기간: 24 months
|
Preservation of range of movement (expressed in degrees) at the index and adjacent levels at baseline compared to follow-up using flexion/extension radiographs |
24 months
|
|
Exploratory Endpoint: Neurological Status
기간: 3 months
|
Maintenance and/or improvement of baseline neurologic status through physical assessment evaluating nerve compression at baseline and post-surgical follow-up using pain, motor strength, and sensation feedback from the patient on a 0 (no compression) to 5 (major compression) scale |
3 months
|
|
Exploratory Endpoint: Neurological Status
기간: 6 months
|
Maintenance and/or improvement of baseline neurologic status through physical assessment evaluating nerve compression at baseline and post-surgical follow-up using pain, motor strength, and sensation feedback from the patient on a 0 (no compression) to 5 (major compression) scale |
6 months
|
|
Exploratory Endpoint: Neurological Status
기간: 12 months
|
Maintenance and/or improvement of baseline neurologic status through physical assessment evaluating nerve compression at baseline and post-surgical follow-up using pain, motor strength, and sensation feedback from the patient on a 0 (no compression) to 5 (major compression) scale |
12 months
|
|
Exploratory Endpoint: Neurological Status
기간: 24 months
|
Maintenance and/or improvement of baseline neurologic status through physical assessment evaluating nerve compression at baseline and post-surgical follow-up using pain, motor strength, and sensation feedback from the patient on a 0 (no compression) to 5 (major compression) scale |
24 months
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .